Cresco Labs (OTCMKTS:CRLBF - Get Free Report) will likely be issuing its quarterly earnings data before the market opens on Friday, May 9th. Analysts expect the company to announce earnings of ($0.03) per share and revenue of $165.48 million for the quarter.
Cresco Labs (OTCMKTS:CRLBF - Get Free Report) last posted its quarterly earnings results on Friday, March 14th. The company reported ($0.01) EPS for the quarter, hitting the consensus estimate of ($0.01). The company had revenue of $176.00 million during the quarter, compared to analysts' expectations of $172.10 million. Cresco Labs had a negative net margin of 9.15% and a negative return on equity of 16.52%. On average, analysts expect Cresco Labs to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Cresco Labs Stock Down 2.2 %
Shares of Cresco Labs stock traded down $0.02 during trading on Wednesday, hitting $0.84. 193,571 shares of the stock were exchanged, compared to its average volume of 637,683. The stock has a market cap of $411.23 million, a price-to-earnings ratio of -4.19 and a beta of 1.73. The firm's 50-day moving average price is $0.72 and its 200 day moving average price is $0.95. The company has a debt-to-equity ratio of 1.80, a current ratio of 1.97 and a quick ratio of 1.39. Cresco Labs has a 12-month low of $0.52 and a 12-month high of $2.35.
Analyst Ratings Changes
Separately, Cormark upgraded shares of Cresco Labs from a "hold" rating to a "moderate buy" rating in a research report on Monday, March 17th. Two equities research analysts have rated the stock with a hold rating, one has issued a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat.com, Cresco Labs presently has an average rating of "Buy" and an average target price of $3.00.
Read Our Latest Analysis on Cresco Labs
About Cresco Labs
(
Get Free Report)
Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.
Further Reading

Before you consider Cresco Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cresco Labs wasn't on the list.
While Cresco Labs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.